Rolapitant and Abametapir: Interaction Details
- Rolapitant
- Varubi
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Rolapitant and Abametapir interaction:
Abametapir
We don't have a drug information page for Abametapir because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Abametapir? Ask a pharmacist, free →
What Happens When You Take Rolapitant With Abametapir
What can happen when they are taken together (rated Major)
Increased exposure of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
CYP3A4 substrates should not be used during the 2 weeks following abametapir application. When that cannot be arranged, abametapir should not be used.1
The Rolapitant and Abametapir Interaction, Explained
Abametapir is a lotion used to treat head lice. It can block an enzyme in your body called , which helps clear many medicines. Rolapitant (Varubi) is used to prevent nausea and vomiting after chemotherapy. If the enzyme is slowed down, the levels of some medicines can build up. This is based on lab and theoretical reasoning, not on large studies in people. The label for abametapir advises avoiding medicines that rely on this enzyme for about 2 weeks after using it.
If you have a lice treatment and chemotherapy coming up, tell your pharmacist or doctor. They can decide on the timing or choose another option. Please do not stop or change any medicine on your own.
Mechanism: Abametapir inhibits , so exposure to CYP3A4 may increase. Rolapitant is a CYP3A4 substrate (it is also a and / ), so its exposure and adverse effects could increase. Neither drug is a , so the direction is increased exposure.
- Evidence: theoretical, with no specific clinical data on this pair. Onset is rapid, and may persist for about 2 weeks after application.
- Severity on file: major.
- Management: avoid CYP3A4 substrates within 2 weeks after abametapir application. If that is not feasible, avoid abametapir. Consider an alternative pediculicide if rolapitant is needed.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Rolapitant and Abametapir Interact
The likely mechanism
of -mediated by abametapir
How to Manage the Rolapitant and Abametapir Interaction
Your care team can manage this, mainly through timing and choice of treatment.
- Keep taking your medicines as prescribed unless your prescriber tells you otherwise.
- Tell your pharmacist or prescriber about any plan to use abametapir lotion, especially if you take or are about to take rolapitant.
- The documented advice is to avoid -dependent medicines for 2 weeks after abametapir. If that is not possible, your team may choose a different lice treatment.
- Ask before starting any new medicine or lice product.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Rolapitant or Abametapir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Rolapitant and Abametapir: Common Questions
How serious is the Rolapitant and Abametapir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Rolapitant and Abametapir interaction managed?
Your care team can manage this, mainly through timing and choice of treatment. Keep taking your medicines as prescribed unless your prescriber tells you otherwise. Tell your pharmacist or prescriber about any plan to use abametapir lotion, especially if you take or are about to take rolapitant. The documented advice is to avoid -dependent medicines for 2 weeks after abametapir. If that is no… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Rolapitant and Abametapir Interaction
Ask in your own words about taking Rolapitant and Abametapir together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: XEGLYZE(TM) topical lotion, abametapir topical lotion. Dr Reddy’s Laboratories Inc (per FDA), Princeton, NJ, 2020. DailyMed
Other Serious Interactions of Rolapitant and Abametapir
Also serious with Abametapir
Also serious with Rolapitant
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Abametapir
- Green TeaModerate
- CannabisModerate
- YohimbeModerate
- Pu-erh TeaModerate
- Black TeaModerate
- AdrafinilModerate
- Cannabidiol (CBD)Moderate
- Cannabinol (CBN)Moderate
- + 14 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.